BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1683 related articles for article (PubMed ID: 1709109)

  • 41. Granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor: differential action on incisional wound healing.
    Jyung RW; Wu L; Pierce GF; Mustoe TA
    Surgery; 1994 Mar; 115(3):325-34. PubMed ID: 7510423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stem cell factor augments tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-mediated dendritic cell hematopoiesis.
    Santiago-Schwarz F; Rappa DA; Laky K; Carsons SE
    Stem Cells; 1995 Mar; 13(2):186-97. PubMed ID: 7540472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased yield of myeloid progenitor cells in bone marrow harvested for autologous transplantation by pretreatment with recombinant human granulocyte-colony stimulating factor.
    Johnsen HE; Hansen PB; Plesner T; Jensen L; Gaarsdal E; Andersen H; Hansen SW; Birgens H; Jacobsen GK; Kjaersgaard E
    Bone Marrow Transplant; 1992 Sep; 10(3):229-34. PubMed ID: 1384899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K
    J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effects of IL-3, GM-CSF and G-CSF in an adult with congenital neutropenia.
    Miyachi H; Nakamura Y; Shimizu H; Watanabe K; Arimori S; Ando Y
    Int J Hematol; 1992 Oct; 56(2):113-8. PubMed ID: 1384774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synergy between recombinant human IL-1 alpha (rHuIL-1) and M-CSF (rHuM-CSF) during the recovery of murine hematopoietic activity in myelosuppressed animals: abbreviated versus chronic administration of rHuM-CSF.
    Kovacs CJ; Harrell JP; Gooya JM; Evans MJ; Johnke RM
    Exp Hematol; 1992 Jun; 20(5):582-9. PubMed ID: 1587305
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of interleukin-11 with and without granulocyte colony-stimulating factor on in vivo neonatal rat hematopoiesis: induction of neonatal thrombocytosis by interleukin-11 and synergistic enhancement of neutrophilia by interleukin-11 + granulocyte colony-stimulating factor.
    Cairo MS; Plunkett JM; Nguyen A; Schendel P; van de Ven C
    Pediatr Res; 1993 Jul; 34(1):56-61. PubMed ID: 7689197
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment severely depresses murine marrow erythropoiesis without causing an anemia.
    de Haan G; Loeffler M; Nijhof W
    Exp Hematol; 1992 Jun; 20(5):600-4. PubMed ID: 1375161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preclinical studies on synergistic effects of IL-1, IL-3, G-CSF and GM-CSF in cynomolgus monkeys.
    Krumwieh D; Weinmann E; Siebold B; Seiler FR
    Int J Cell Cloning; 1990 Jan; 8 Suppl 1():229-47; discussion 247-8. PubMed ID: 1691245
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemopoietic effects of short-term in vivo treatment of mice with various doses of rhG-CSF.
    Pojda Z; Molineux G; Dexter TM
    Exp Hematol; 1990 Jan; 18(1):27-31. PubMed ID: 1688807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased respiratory burst activity of neutrophils in patients with aplastic anemia: effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor.
    Ohsaka A; Kitagawa S; Yuo A; Motoyoshi K; Ohta M; Miura Y; Takaku F; Saito M
    Exp Hematol; 1992 Oct; 20(9):1090-3. PubMed ID: 1281785
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Defibrotide in combination with granulocyte colony-stimulating factor significantly enhances the mobilization of primitive and committed peripheral blood progenitor cells in mice.
    Carlo-Stella C; Di Nicola M; Magni M; Longoni P; Milanesi M; Stucchi C; Cleris L; Formelli F; Gianni MA
    Cancer Res; 2002 Nov; 62(21):6152-7. PubMed ID: 12414641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages.
    Wiktor-Jedrzejczak W; Ratajczak MZ; Ptasznik A; Sell KW; Ahmed-Ansari A; Ostertag W
    Exp Hematol; 1992 Sep; 20(8):1004-10. PubMed ID: 1505635
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon-gamma and interleukin-4 reciprocally regulate the production of monocytes/macrophages and neutrophils through a direct effect on committed monopotential bone marrow progenitor cells.
    Snoeck HW; Lardon F; Lenjou M; Nys G; Van Bockstaele DR; Peetermans ME
    Eur J Immunol; 1993 May; 23(5):1072-7. PubMed ID: 7682957
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics of rG-CSF-induced neutrophilia in mice.
    Uchida T; Yamagiwa A
    Exp Hematol; 1992 Feb; 20(2):152-5. PubMed ID: 1371963
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant human granulocyte colony-stimulating factor enhanced the resolution of venous thrombi.
    Chen YK; Jiang XM; Gong JP
    J Vasc Surg; 2008 May; 47(5):1058-65. PubMed ID: 18358673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo regulation of hemopoiesis by transforming growth factor beta 1: stimulation of GM-CSF- and M-CSF-dependent murine bone marrow precursors.
    Bursuker I; Neddermann KM; Petty BA; Schacter B; Spitalny GL; Tepper MA; Pasternak RD
    Exp Hematol; 1992 May; 20(4):431-5. PubMed ID: 1568460
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hematopoietic recovery following high-dose combined alkylating-agent chemotherapy and autologous bone marrow support in patients in phase-I clinical trials of colony-stimulating factors: G-CSF, GM-CSF, IL-1, IL-2, M-CSF.
    Laughlin MJ; Kirkpatrick G; Sabiston N; Peters W; Kurtzberg J
    Ann Hematol; 1993 Dec; 67(6):267-76. PubMed ID: 7506580
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [A successful case of congenital agranulocytosis treated with recombinant human granulocyte colony-stimulating factor].
    Shimokawa T; Suzue T; Matsutomo S; Okabe K; Toki H
    Rinsho Ketsueki; 1990 Oct; 31(10):1694-7. PubMed ID: 1701502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.